ARTICLE | Company News
Akzo Nobel NV, Pfizer deal
July 4, 2005 7:00 AM UTC
AKZ's Organon unit (Oss, the Netherlands) received an undisclosed milestone payment from PFE under a 2003 deal to develop and market Organon's asenapine serotonin (5-HT2) and dopamine (D2) receptor an...